Month: February 2025

Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Written by Customer Service on February 27, 2025. Posted in Public Companies.

NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, today announced that Meg Alexander, President and Chief Operating Officer, will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 3:10 p.m. ET in Boston, Massachusetts. A live webcast of the TD Cowen presentation can be accessed through the Events & Presentations section of the company’s website at investors.ovidrx.com. An archived replay of the webcast will be available on the Company’s website following the live presentation for approximately 30 days. About Ovid TherapeuticsOvid Therapeutics Inc. is a New York-based biopharmaceutical company dedicated to developing medicines for brain conditions...

Captivision Appoints John Jureller to Board of Directors

Written by Customer Service on February 27, 2025. Posted in Public Companies.

MIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) — Captivision Inc. (“Captivision” or the “Company”) (NASDAQ: CAPT), a pioneering manufacturer and global LED solution provider, today announced the appointment of John Jureller to its Board of Directors, effective immediately. Mr. Jureller will also serve as Chair of the Company’s Audit Committee, bringing extensive financial leadership and corporate governance expertise to the Company. With experience spanning consumer products, communications, private equity, real estate, and healthcare, Mr. Jureller has held key financial leadership roles at multinational public and private companies. He has played an instrumental role in growth capitalizations and strategic transactions for small and micro-cap companies. His former corporate affiliations include PepsiCo, Frontier Communications, General...

ZenaTech’s ZenaDrone Advances IQ Square Drone to Manufacturing Stage for Outdoor Applications Including Inspections, Surveys, and the Fast-Growth Power Washing Sector

Written by Customer Service on February 27, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 27, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces that its subsidiary ZenaDrone has moved its first batch of IQ Square multifunction drones from prototype to manufacturing stage. This drone was designed for outdoor applications for operator line-of-site inspections such as for building and construction inspections, short-range land surveys, power washing and other business and government applications. The IQ Square is also expected to be a key part of ZenaDrone’s multifunction drone inventory for its Drone as a Service or DaaS business, which enables business and government users to...

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

Written by Customer Service on February 27, 2025. Posted in Public Companies.

The $2 million in new funding is part of a $4 million commitment from Teva, launched in 2022, to expand access to critical mental health services across 10 states SANTA BARBARA, Calif. and PARSIPPANY, N.J. , Feb. 27, 2025 (GLOBE NEWSWIRE) — Direct Relief, Teva Pharmaceuticals, and the National Association of Free and Charitable Clinics (NAFC) today announced the funding of Community Routes: Access to Mental Health Care grants, awarding $75,000 to each of 11 free and charitable clinics across Alabama, Mississippi, and Texas. Now in its third year, the initiative continues to address the critical need for expanded mental health services in medically underserved communities. “Every day uninsured patients face barriers to accessing basic mental health services they need,” said Carol Richardson, Sustainability and Health Equity Lead,...

NEXE Innovations Secures Fourth Partnership, Expanding its Audience in Canada and the United States

Written by Customer Service on February 27, 2025. Posted in Public Companies.

A vertically integrated facility, from compounding NEXE’s proprietary resin to producing the finished product.WINDSOR, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) — NEXE Innovations Inc. (“NEXE”, the “Company”, “we” or “our”) (TSX.V: NEXE | Frankfurt: NX5 | OTC: NEXNF), a compostable and innovative materials company, is pleased to announce a fourth partnership with a North American distributor specializing in retail, office coffee services (OCS) and hospitality sectors. We believe that this new partnership represents a significant milestone for NEXE, as this partner was among the first to capitalize on the multi-billion-dollar single-serve coffee market following the expiration of the K-Cup patent in 2013 in both Canada and the U.S. Now, they are strengthening their...

Telesat Partners with Intellian to Develop Ka-Band Flat Panel User Terminals for Telesat Lightspeed LEO Constellation

Written by Customer Service on February 27, 2025. Posted in Public Companies.

OTTAWA, Ontario and PYEONGTAEK, South Korea, Feb. 27, 2025 (GLOBE NEWSWIRE) — Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative satellite operators, and Intellian, a global leading provider of satellite communication antennas and ground gateway solutions, today announced a contract award for Intellian to design and manufacture Ka-band flat panel User Terminals for the Telesat Lightspeed Low Earth Orbit (LEO) constellation. Under this agreement, fully optimized Ka-band LEO flat panels for the Telesat Lightspeed network are being designed and manufactured to deliver high-speed throughput for markets including fixed enterprise applications, wireless backhaul, government, land mobility and maritime connectivity. Intellian is trusted by customers worldwide, recognized for its exceptional reliability and...

Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Written by Customer Service on February 27, 2025. Posted in Earnings Releases And Operating Results.

Targeting NDA submission for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 through accelerated approval pathway; on track to initiate APOLLO post-marketing confirmatory trial by mid-2025 Positive update from Phase 1b trial of DISC-0974 in patients with anemia of myelofibrosis (MF) presented at ASH 2024; initial data from ongoing Phase 2 expected in H2 2025 Positive data from initial cohorts of ongoing Phase 1b study of DISC-0974 in patients with anemia of non-dialysis-dependent chronic kidney disease (NDD-CKD) presented at ASN Kidney Week 2024; initial data from multiple dose portion of this study expected in H2 2025 Presented first-in-human SAD/MAD data from Phase 1 trial of DISC-3405 demonstrating proof-of-mechanism; a Phase 2 study in polycythemia vera (PV) expected to initiate in H1 2025 Strong financial position ending...

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Written by Customer Service on February 27, 2025. Posted in Earnings Releases And Operating Results.

Full-Year Total Revenue Growth of 20% to $237.2 Million, with MACI Revenue Growth of 20% and Burn Care Revenue Growth of 22% Full-Year Adjusted EBITDA Growth of 58% to $53.4 Million Record Fourth Quarter Gross Margin of 78%, Adjusted EBITDA Margin of 40%, and Net Income of $19.8 Million Mid-Term Profitability Targets Increased to Gross Margin in the High-70% Range and Adjusted EBITDA Margin in the High-30% Range Strong MACI Arthro Key Launch Indicators, with Approximately 250 MACI Arthro Surgeons Trained to Date 2025 Financial Guidance with Total Revenue Growth of 20% to 23% Reaffirmed Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial results...

Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook

Written by Customer Service on February 27, 2025. Posted in Earnings Releases And Operating Results.

2024 net revenues increased 4.9% to $1.10 billion, compared to 2023; or 5.4% on a constant currency basis 2024 net income of $44 million or $0.16 per diluted share, compared to 2023 2024 Adjusted EBITDA(1) increased 3.9% to $549 million, compared to 2023; or 4.6% on a constant currency basis 2024 Adjusted EPS(1) of $0.70, a decrease of $0.02 per diluted share, compared to 2023 Full-year 2025 outlook of 4.0% – 6.0% net revenues growth and 4.5% – 6.5% Adjusted EBITDA growth, both on a constant currency basisCLEVELAND, Feb. 27, 2025 (GLOBE NEWSWIRE) — Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the fourth-quarter...

GoHealth Reports Strong Fourth Quarter and Fiscal Year 2024 Results, Driven by a Successful Annual Enrollment Period

Written by Customer Service on February 27, 2025. Posted in Earnings Releases And Operating Results.

CHICAGO, Feb. 27, 2025 (GLOBE NEWSWIRE) — GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and twelve months ended December 31, 2024. Fourth Quarter HighlightsAchieved net revenues of $389.1 million, a substantial 41% increase compared to the prior year period.Submissions grew to 481,445, representing a 67% increase compared to the prior year period.Net income of $58.0 million, a substantial improvement of $60.3 million compared to the prior year period.Adjusted EBITDA1 surged to $117.8 million, a significant 107% increase compared to the prior year period.Compared to the prior year period, Direct Operating Cost per Submission2 improved 27%, to an industry leading $501.The...

Month: February 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals